President, CEO of Cadence Pharmaceuticals Inc. (CADX, Financial) Theodore R Schroeder sells 50,000 shares of CADX on 04/01/2010 at an average price of $9.18 a share.
Cadence Pharmaceuticals Inc. has a market cap of $454.5 million; its shares were traded at around $9 .
CADX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Steven Cohen of SAC Capital Advisors.
Cadence Pharmaceuticals Inc. has a market cap of $454.5 million; its shares were traded at around $9 .
CADX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Steven Cohen of SAC Capital Advisors.
CEO Recent Trades:
- Sell:: President, CEO Theodore R Schroeder sold 30,000 shares of CADX stock on 01/04/2010 at the average price of 9.77, the price of the stock has decreased by 7.88% since.
- Sell:: President, CEO Theodore R Schroeder sold 20,000 shares of CADX stock on 10/16/2009 at the average price of 10.72, the price of the stock has decreased by 16.04% since.
Directors and Officers Recent Trades:
- Sell:: SVP David A Socks sold 10,000 shares of CADX stock on 03/08/2010 at the average price of 9.3, the price of the stock has decreased by 3.23% since.
- Sell:: SVP David A Socks sold 12,500 shares of CADX stock on 02/08/2010 at the average price of 10.26, the price of the stock has decreased by 12.28% since.
- Sell:: EVP, CMO James B Breitmeyer sold 1,000 shares of CADX stock on 02/01/2010 at the average price of 10, the price of the stock has decreased by 10% since.
- Sell:: SVP David A Socks sold 12,500 shares of CADX stock on 01/11/2010 at the average price of 10.06, the price of the stock has decreased by 10.54% since.
- Sell:: EVP, CMO James B Breitmeyer sold 1,000 shares of CADX stock on 01/05/2010 at the average price of 10, the price of the stock has decreased by 10% since.
